Central Laboratories Products/Services

  1. Targeted Source Data Verification 2/6/2025

    Ergomed’s Risk-Based Clinical Monitoring and Source Data Verification Approach for Data Integrity

    Ergomed ensures the highest data integrity and patient safety standards through our risk-based clinical monitoring and Source Data Verification (SDV) practices. SDV is a critical process in clinical trials that ensures the data collected are accurate, complete, and verifiable against the source documents. We compare data entered into case report forms or electronic data capture systems with the source data to confirm their accuracy and reliability.

  2. Suvoda RTSM (IRT) 9/16/2025

    A centralized command center for patient randomization and drug supply management—built for today’s complex clinical trials.

  3. Power Meets User-Centricity With Curebase EDC 8/29/2024

    Seamlessly integrated with Curebase’s ePRO/eCOA suite, our EDC enables hybrid and site-based studies that users will love and that streamline all of your data collection into a single, modern experience.

  4. Medical Writing Software 6/17/2025

    Accelerate Medical Writing Without Compromising Accuracy or Compliance

    In the fast-paced world of clinical research, the ability to produce, review, and finalize high-quality documents—on time and with full regulatory compliance—is non-negotiable. Ideagen Document Review (formerly known as PleaseReview) is the trusted collaboration and co-authoring platform that enables clinical teams to streamline document reviews, reduce version chaos, and ensure traceable, auditable feedback across the board.

  5. Revvity Signals Software Signals™ Medical Review 8/28/2017

    See our exciting new solution for medical monitors, Revvity Signals Software Signals™ Medical Review which empowers clinical development teams and medical monitors to detect safety signals faster and reduce time to submission by combining innovative medical review workflow with advanced analytics.

  6. Commercialization And Outcomes 5/17/2018

    ICON Commercialization & Outcomes (ICO) optimizes the value of drugs and medical devices through innovative strategies and tactics that reflect evolving evidentiary, regulatory, and reimbursement requirements.

  7. AI-Powered Workflows: Accelerating Trial Execution 4/1/2026

    What can 22,000 people with an AI-mindset accomplish?

    Speed without shortcuts

    AI in clinical development at Parexel enables our teams to surface predictive insights at every stage, reducing protocol risk, study delays, and costly trial amendments.

    Parexel's approach to AI in clinical development is built on the Precision Pathway, a strategic operating model that embeds AI across the full trial lifecycle. AI empowers our teams at critical decision points to:

    1. Simplify complex tasks to accelerate timelines: AI capabilities are delivering up to 50% cycle time reductions in IND submission generation.
    2. Apply insights with agility to enable better decision-making
    3. Enhance data handling to drive first-time quality through content generation and workflow automation